Answers are grounded in this paper and cite their sources.
Qdenga (Takeda) is now WHO recommended for residents of highly endemic areas. Travellers from dengue non-endemic countries with previous travel-related dengue (any serotype) will benefit from TAK-003 vaccination to prevent a secondary dengue infection during future dengue risk travel. Dengue-naïve travellers have less potential benefit and use will remain discretionary for now.
No takes yet. Share an insight, caveat, or question.
David O. Freedman (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: